Objective To explore the effect of the integrin αvβ3 inhibitor Cilengitide on the blood brain barrier ( BBB) permeability, brain edema, neuronal cell apoptosis and the relation with the vascular endothelial growth factor ( VEGF) expression in acute cerebral ischemia rats.Methods A rat focal cerebral ischemia/reperfusion model was established by middle cerebral artery occlusion.Rats with middle cerebral artery occlusion, in accordance with the random number table, were divided into four groups:(1) the rats in Cilengitide group A ( n =30 ) were treated with Cilengitide at a dose of 100 μg/kg; ( 2 ) the rats in Cilengitide group B (n=28) were treated with Cilengitide at a dose of 200 μg/kg; (3) the rats in sham group (n=31), without inserting thread into middle cerebral artery,were treated with normal saline; (4) the rats in control group ( n=27 ) were treated with normal saline.All rats were treated with Cilengitide or saline 1 hour after infarction, given reperfusion 2 hours after infarction and were sacrificed 22 hours after reperfusion.The brain-water content was measured by dry/wet weight method.The permeability of BBB was measured by quantifying Evans Blue.The infarction volume was measured by 2,3,5-tripheyl tetrazolium Chloride ( TTC ) staining.Expression level of VEGF, P-Flk, Cleaved-Caspase-3 was measured by immunohistochemistry and Western blot, respectively.The neuronal cell apoptosis was evaluated by terminal deoxynucleotidyl transferased UTP nick end labeling ( TUNEL) .Results Compared with Control group, treatment groups with cilengitide at the dose of 100 μg/kg and 200 μg/kg reduced brain-water content [(80.8 ±1.1)%vs (84.8 ±1.4)%,(81.0 ±1.4)%vs (84.8 ±1.4)%, P<0.05],reduced exudation of Evans blue[(9.2 ±1.1) μg/g vs (12.2 ±0.8) μg/g,(8.6 ±0.6) μg/g vs (12.2 ±0.8) g/g,P<0.05],reduced infarction volume[(31.9 ±4.9) mm3 vs(43.0 ±2.2) mm3,(29.2 ±3.5) mm3 vs(43.0 ± 2.2) mm3,P<0.05] ,reduced neuronal cell apoptosis [(36 ±4)vs(69 ±6)、(35 ±3)vs (69 ±6), P<0.05].Compared with sham group, Cilengitide group A and Cilengitide group B had lower brain-water content, permeability of BBB, infarction volume, expression level of VEGF, P-Flk, Cleaved-Caspase-3 and neuronal cell apoptosis (P<0.05).When Cilengitide group A was compared with Cilengitide group B, there were no significant differences in brain-water content, permeability of BBB, infarction volume, expression level of VEGF, P-Flk, Cleaved-Caspase-3 and neuronal cell apoptosis ( P >0.05 ) .Conclusion The integrinαvβ3 inhibitor Cilengitide improves outcomes in the MCAO model by preserving the blood-brain barrier, attenuating brain edema and inhibiting neuronal cell apoptosis, which may occur in a VEGF-and VEGF-receptor-dependent manner, with the same efficacy between Cilengitide 100 μg/kg and 200 μg/kg after 23 hours treatment.